1 / 15

EQA-LSD External Q uality A ssessment Enzyme Analysis for L ysosomal S torage D iseases

Explore reproducibility results of enzyme activities in fibroblasts for lysosomal storage diseases. Analyze 14 key enzymes measured in 2013 EQA with CV statistics.

Download Presentation

EQA-LSD External Q uality A ssessment Enzyme Analysis for L ysosomal S torage D iseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pilots “large scale” 2006 (36) 2007 (46) 2008 (55) 2009 (59), DBS (27) 2010 (58) 2011 (61) 2012 (64) 2013 (71) EQA-LSD External Quality Assessment Enzyme Analysis for Lysosomal Storage Diseases

  2. ENZYMES 2013 PROFICIENCY TESTINGFIBROBLASTS Hurler/Scheie (MPS I) α-L-iduronidase Krabbe Galactocerebrosidase LF2 Niemann Pick A/B Sphingomyelinase LF4 Fabry α-galactosidase Gaucherβ-Glucosidase Sanfilippo A Heparansulphate sulphamidase LF6 MPS VI, Arylsulphatase B GM1(Morquio B) β-Galactosidase GM2 β-Hexosaminidase A+B LF1 Pompeα-Glucosidase LF 3 + 5 control Fibroblasts used for determination CV 2

  3. RESULTS 2013 NUMBER OF ENZYMES MEASURED 3

  4. Reproducibility of protein/vial 2013duplicate samples Fibroblasts Mean CV 15.5±27.7 % 4

  5. Reproducibility of Arylsulfatase B 2013duplicate samples Fibroblasts D+ enzyme activity other samples < 20 % control Fibroblasts Mean CV 35 ± 36 % D incorrect 2% 5

  6. Reproducibility of α-Galactosidase 2013duplicate samples Fibroblasts Mean CV 16 ± 15 % D incorrect 0% 6

  7. Reproducibility of β-Galactosidase 2013duplicate samples Fibroblasts D+ enzyme activity other Fibroblast < 20 % control Fibroblast Mean CV 29 ± 36 % D incorrect 3% 7

  8. Reproducibility of α-Glucosidase 2013duplicate samples Fibroblasts D+ enzyme activity other Fibroblast< 20 % control Fibroblast Mean CV 27 ± 28 % D incorrect 5 % 8

  9. Reproducibility of β-Glucosidase 2013duplicate samples Fibroblasts Mean CV 27 ± 30 % D incorrect 0% 9

  10. Reproducibility of β-Hexosaminidase A+B 2013duplicate samples Fibroblasts D+ enzyme activity other Fibroblast < 20 % control Fibroblast D0 patient sample not measured Mean CV 28 ± 33 % D incorrect 8% 10

  11. Reproducibility of α-Iduronidase 2013duplicate samples Fibroblasts D+ enzyme activity other Fibroblast < 20 % control Fibroblast Mean CV 30 ± 35 % D incorrect 2 % 11

  12. Reproducibility of Heparansulphate sulphamidase 2013 duplicate samples Fibroblasts D- enzyme activity patient sample > 30% control Fibroblast D+ enzyme activity other Fibroblast < 20 % control Fibroblast D0 patient sample not measured Mean CV 33 ± 44 % D incorrect 26% 12

  13. Reproducibility of Galactocerebrosidase 2013duplicate samples Fibroblasts D- enzyme activity patient sample > 30% control Fibroblast D+ enzyme activity other Fibroblast< 20 % control Fibroblast D0 patient sample not measured Mean CV 38± 35 % D incorrect 33% 13

  14. Reproducibility of Sphingomyelinase 2013duplicate samples Fibroblasts D- enzyme activity patient sample > 30% control Fibroblast D+ enzyme activity other Fibroblast < 20 % control Fibroblast D0 patient sample not measured Mean CV 44 ± 63 % D incorrect 10% 14

  15. OVERALL PERFORMANCE 2013 10 Participants: 100% score, CV<25%; enzyme patient<30%; enzyme control >20% 44 Participants: no false negative of positive patients 15

More Related